duloxetine hydrochloride has been researched along with Encephalopathy, Toxic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 6 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bornhorst, J; Brinkmann, V; Fritz, G; Honnen, S; Ventura, N; Wellenberg, A | 1 |
| DiGiacomo, DF; Gibson, AA; Hu, S; Jin, Y; Li, Y; Lustberg, MB; Nepal, MR; Sparreboom, A; Taheri, H; Talebi, Z; Uddin, ME | 1 |
| Aghabozorgi, R; Babaee, M; Hashemi, M; Hesam, M; Rayegani, SM; Zahed, G | 1 |
| Bautista, J; Brown, JS; Curtis, LH; Dworkin, RH; Gewandter, JS; Kleckner, AS; Kleckner, IR; Kolb, N; Marshall, JH; Mohile, SG; Mustian, KM | 1 |
| Cavaletti, G; Islam, B; Lustberg, M; Psimaras, D; Staff, NP; Tamburin, S | 1 |
| Alberti, P; Argyriou, AA; Demichelis, C; Park, SB; Schenone, A; Tamburin, S | 1 |
| Argyriou, AA; Besora, S; Bruna, J; Calvo, M; Clapés, V; Gil-Gil, M; Izquierdo, C; Jiménez, L; Palmero, R; Pardo, B; Sala, R; Santos, C; Simó, M; Velasco, R | 1 |
| Balayssac, D; Busserolles, J; Farsi, F; Guastella, V; Kerckhove, N; Merle, P; Pereira, B; Pezet, D; Selvy, M | 1 |
2 review(s) available for duloxetine hydrochloride and Encephalopathy, Toxic
| Article | Year |
|---|---|
Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment.
Topics: Antineoplastic Agents; Cisplatin; Duloxetine Hydrochloride; Humans; Neurotoxicity Syndromes; Organoplatinum Compounds; Oxaliplatin; Peripheral Nervous System Diseases; Serotonin and Noradrenaline Reuptake Inhibitors; Treatment Outcome | 2019 |
Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment.
Topics: Antineoplastic Agents; Bridged-Ring Compounds; Clinical Trials as Topic; Duloxetine Hydrochloride; Epothilones; Humans; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Prospective Studies; Serotonin and Noradrenaline Reuptake Inhibitors; Taxoids; Treatment Outcome; Tubulin Modulators | 2019 |
1 trial(s) available for duloxetine hydrochloride and Encephalopathy, Toxic
| Article | Year |
|---|---|
Efficacy of Duloxetine on electrodiagnostic findings of Paclitaxel-induced peripheral neuropathy, does it have a prophylactic effect? A randomized clinical trial.
Topics: Breast Neoplasms; Duloxetine Hydrochloride; Female; Humans; Neurotoxicity Syndromes; Paclitaxel; Peripheral Nervous System Diseases | 2023 |
5 other study(ies) available for duloxetine hydrochloride and Encephalopathy, Toxic
| Article | Year |
|---|---|
Cisplatin-induced neurotoxicity involves the disruption of serotonergic neurotransmission.
Topics: Animals; Antineoplastic Agents; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Cisplatin; Disease Models, Animal; Duloxetine Hydrochloride; Female; Gene Expression Regulation; Neurotoxicity Syndromes; Pharynx; Serotonin; Serotonin and Noradrenaline Reuptake Inhibitors; Synaptic Transmission | 2021 |
Targeting OCT2 with Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neurotoxicity.
Topics: Animals; Antineoplastic Agents; Duloxetine Hydrochloride; Humans; Mice; Neurotoxicity Syndromes; Oxaliplatin; Peripheral Nervous System Diseases | 2022 |
Chemotherapy-induced peripheral neuropathy (CIPN) and its treatment: an NIH Collaboratory study of claims data.
Topics: Analgesics; Antineoplastic Agents; Duloxetine Hydrochloride; Female; Humans; Incidence; Insurance, Health; Male; Middle Aged; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Pregabalin; Randomized Controlled Trials as Topic; Retrospective Studies; United States | 2020 |
Duloxetine against symptomatic chemotherapy-induced peripheral neurotoxicity in cancer survivors: a real world, open-label experience.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Cancer Survivors; Duloxetine Hydrochloride; Female; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasms; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Prognosis; Prospective Studies; Quality of Life; Serotonin and Noradrenaline Reuptake Inhibitors | 2021 |
Prevention, diagnosis and management of chemotherapy-induced peripheral neuropathy: a cross-sectional study of French oncologists' professional practices.
Topics: Adult; Amitriptyline; Antineoplastic Agents; Calcium; Cross-Sectional Studies; Duloxetine Hydrochloride; France; Gabapentin; Humans; Magnesium; Male; Middle Aged; Neurotoxicity Syndromes; Oncologists; Peripheral Nervous System Diseases; Practice Patterns, Physicians'; Pregabalin; Surveys and Questionnaires; Vitamins | 2021 |